(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RNANTIGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

RNANTIGEN

ST13

US500000077067574

Class

1, 5, 44

Filing

77067574

Registration

3478720

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

03/08/2023

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 44

Filing date

12/19/2006

Registration date

08/05/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/13/2018

Last transaction

08/13/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Drawing code

4

Owner type

94

Owner location

TÜBINGEN, DE

Examiner

CHOSID, ROBIN

Law office

L20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

C. S. (pessoa física)
CUREVAC AG
CureVac GmbH

Representatives

Jennifer Fraser Dykema Gossett PLLC

Technical classification

Nice Classes

Class 1Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

chemicals used in industry and science; reagents for research use

Class 5

Chemical preparations for medical purposes; pharmaceutical and veterinary preparationsin particular chemotherapeutics for the treatment of tumorscardiac drugs and preparations for the treatment of asthmareceptor agonists and receptor antagonists for modulating receptor-mediated disorderspharmaceutics for the treatment of neurological disordersfor the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic substances adapted for medical usein particular substances for food supplements; disinfectants for sanitary purposes; fungicides; herbicides for medical purposes

Class 44

medical services

Publications

History of USPTO decisions and trademark events.

43 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/08/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/13/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/13/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/13/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/13/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

08/01/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/05/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/12/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/23/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/20/2015

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/20/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/20/2015

E815

TEAS SECTION 8 & 15 RECEIVED

02/04/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

08/05/2008

PUBO

PUBLISHED FOR OPPOSITION

05/20/2008

NPUB

NOTICE OF PUBLICATION

04/30/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/14/2008

ALIE

ASSIGNED TO LIE

04/14/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/07/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/03/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/03/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/03/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/29/2008

GNRT

NON-FINAL ACTION E-MAILED

02/29/2008

AAUD

AMENDMENT OF ALLEGED USE DISAPPROVED

02/29/2008

CPRA

PRIORITY ACTION WRITTEN

02/29/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/06/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/05/2008

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/05/2008

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/05/2007

GNSL

LETTER OF SUSPENSION E-MAILED

11/05/2007

CNSL

SUSPENSION LETTER WRITTEN

11/05/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/15/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/15/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/15/2007

GNRT

NON-FINAL ACTION E-MAILED

04/14/2007

CNRT

NON-FINAL ACTION WRITTEN

04/14/2007

DOCK

ASSIGNED TO EXAMINER

04/12/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/12/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/12/2007

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

02/23/2007

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

02/23/2007

NWAP

NEW APPLICATION ENTERED

12/26/2006

Continuous trademark protection

Get notified about every new filing that threatens RNANTIGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.